• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病R6/2小鼠模型中皮质-纹状体纤维活性降低。

Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.

作者信息

Traficante Anna, Riozzi Barbara, Cannella Milena, Rampello Liborio, Squitieri Ferdinando, Battaglia Giuseppe

机构信息

Department of Neuroscience, Istituto Neurologico Mediterraneo Neuromed, Località Camerelle, Pozzilli, Italy.

出版信息

Neuroreport. 2007 Dec 3;18(18):1997-2000. doi: 10.1097/WNR.0b013e3282f262ca.

DOI:10.1097/WNR.0b013e3282f262ca
PMID:18007201
Abstract

We have used the R6/2 mice to study cortico-striatal glutamatergic transmission by microdialysis in freely moving mice. Basal extracellular striatal glutamate concentrations were lower in R6/2 mice at 12 weeks of age, but not at 6 weeks of age, when neurological symptoms start to develop. In contrast, K-induced glutamate release was blunted in the striatum of R6/2 mice at both 6 and 12 weeks of age as compared with age-matched controls. We also found a substantial reduction in striatal pro-BDNF (brain derived neurotrophic factor) levels associated with no changes in the mature form of BDNF, as assessed by immunoblotting, in 12-week-old R6/2 mice, suggesting a reduced turnover rate of BDNF in the striatum of these mice. These data support the hypothesis of a cortico-striatal dysfunction in Huntington's disease.

摘要

我们使用R6/2小鼠,通过在自由活动的小鼠中进行微透析来研究皮质-纹状体谷氨酸能传递。12周龄的R6/2小鼠纹状体细胞外谷氨酸基础浓度较低,但在6周龄时(此时神经症状开始出现)并非如此。相比之下,与年龄匹配的对照组相比,6周龄和12周龄的R6/2小鼠纹状体中K诱导的谷氨酸释放均减弱。我们还发现,通过免疫印迹评估,12周龄的R%/2小鼠纹状体中前体脑源性神经营养因子(pro-BDNF)水平大幅降低,而成熟形式的BDNF没有变化,这表明这些小鼠纹状体中BDNF的周转率降低。这些数据支持亨廷顿病中皮质-纹状体功能障碍的假说。

相似文献

1
Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.亨廷顿舞蹈病R6/2小鼠模型中皮质-纹状体纤维活性降低。
Neuroreport. 2007 Dec 3;18(18):1997-2000. doi: 10.1097/WNR.0b013e3282f262ca.
2
Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.在MPTP诱导的黑质纹状体变性小鼠模型中,饮食限制会影响纹状体谷氨酸。
Synapse. 2005 Aug;57(2):100-12. doi: 10.1002/syn.20163.
3
Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.亨廷顿病 R6/2 小鼠模型中主要纹状体传入纤维中 BDNF 表达、纹状体形态和运动行为之间的关系。
Genes Brain Behav. 2013 Feb;12(1):108-24. doi: 10.1111/j.1601-183X.2012.00858.x. Epub 2012 Nov 21.
4
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow.亨廷顿转基因小鼠纹状体中的腺苷和谷氨酸细胞外浓度以及丝裂原活化蛋白激酶。腺苷A2A受体的选择性拮抗作用可减少递质外流。
Neurobiol Dis. 2004 Oct;17(1):77-88. doi: 10.1016/j.nbd.2004.05.008.
5
Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.R6/2亨廷顿舞蹈病转基因小鼠纹状体中的谷氨酸毒性具有年龄依赖性,且与谷氨酸转运体水平降低相关。
Neurobiol Dis. 2009 Apr;34(1):78-86. doi: 10.1016/j.nbd.2008.12.017. Epub 2009 Jan 9.
6
Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.纹状体靶标切除后,大脑皮层和黑质中控制脑源性神经营养因子(BDNF)mRNA表达的不同调节机制。
Exp Neurol. 2005 Mar;192(1):142-55. doi: 10.1016/j.expneurol.2004.11.005.
7
Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.纹状体持续表达睫状神经营养因子对正常和R6/1小鼠的行为及基因表达产生负面影响。
J Neurosci Res. 2008 Jun;86(8):1748-57. doi: 10.1002/jnr.21636.
8
Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.有症状的亨廷顿R6/2小鼠纹状体神经元活动亢进:行为状态及重复抗坏血酸治疗的影响
Neuroscience. 2006;137(1):327-36. doi: 10.1016/j.neuroscience.2005.08.062. Epub 2005 Oct 28.
9
Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.亨廷顿舞蹈病小鼠模型中GABA能功能增强:脑源性神经营养因子的逆转作用
J Neurosci Res. 2004 Dec 15;78(6):855-67. doi: 10.1002/jnr.20344.
10
Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions.纹状体兴奋性毒性损伤后脑源性神经营养因子和1型大麻素受体的皮质表达
Neuroscience. 2008 Mar 27;152(3):734-40. doi: 10.1016/j.neuroscience.2007.11.044. Epub 2007 Dec 8.

引用本文的文献

1
Laquinimod treatment in the R6/2 mouse model.拉喹莫德治疗 R6/2 小鼠模型。
Sci Rep. 2017 Jul 10;7(1):4947. doi: 10.1038/s41598-017-04990-1.
2
Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.揭示与利用亨廷顿舞蹈病中的星形胶质细胞功能障碍
Trends Neurosci. 2017 Jul;40(7):422-437. doi: 10.1016/j.tins.2017.05.002. Epub 2017 May 31.
3
Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models.谷氨酸清除的实时成像显示亨廷顿病小鼠模型中纹状体摄取正常。
Nat Commun. 2016 Apr 7;7:11251. doi: 10.1038/ncomms11251.
4
Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease.在亨廷顿舞蹈病R6/2小鼠模型中,TrkB信号受损是脑源性神经营养因子介导的纹状体神经元营养支持减少的基础。
Front Cell Neurosci. 2016 Mar 9;10:37. doi: 10.3389/fncel.2016.00037. eCollection 2016.
5
Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.在亨廷顿舞蹈症的条件性小鼠模型中,缺乏突变型亨廷顿蛋白的皮质传出神经可改善纹状体神经元活性和行为。
J Neurosci. 2015 Mar 11;35(10):4440-51. doi: 10.1523/JNEUROSCI.2812-14.2015.
6
Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.亨廷顿病 ZQ175 基因敲入小鼠模型的神经生理和行为变化特征、MRI 脑容量测定和 1H MRS。
PLoS One. 2012;7(12):e50717. doi: 10.1371/journal.pone.0050717. Epub 2012 Dec 20.
7
Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.亨廷顿舞蹈病中的皮质纹状体功能障碍与谷氨酸转运体1(GLT1):神经元与星形胶质细胞之间的相互作用
Basal Ganglia. 2012 Jul 1;2(2):57-66. doi: 10.1016/j.baga.2012.04.029.
8
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.谷氨酸转运体 1 的上调逆转了亨廷顿病 R6/2 小鼠模型中皮质诱发纹状体抗坏血酸外排的缺陷。
J Neurochem. 2012 May;121(4):629-38. doi: 10.1111/j.1471-4159.2012.07691.x. Epub 2012 Mar 28.
9
Cellular therapy and induced neuronal replacement for Huntington's disease.细胞治疗和诱导性神经元替代治疗亨廷顿病。
Neurotherapeutics. 2011 Oct;8(4):577-90. doi: 10.1007/s13311-011-0075-8.